U.S. FDA`s New Strategic Priorities 2014 - 1018 (2015) is a webinar that covers topics such as:
- Mandated Areas for Annual Reviews
- The FDA`s "Strategic Priorities" for 2014 and Beyond
- Device, Pharmaceutical and Biological Issues
- Tougher Regulatory Science -- What "Better Science" Really Means
- Major / Pending 510(k) Changes
- General CGMP Issues -- Strengthened Compliance
- Lifecycle Requirements
- Safety / Integrity of Global Supply Chain
U.S. FDA`s New Strategic Priorities 2014 - 1018 (2015) is intended for senior attendees involved or interested in:
- QA
- Corporate Management
- R&D
- RA
- Production
- Engineering
- Marketing
